{"id":"https://openalex.org/W3015589350","doi":"https://doi.org/10.1093/bmb/ldaa006","title":"Obeticholic acid\u2014a new therapy in PBC and NASH","display_name":"Obeticholic acid\u2014a new therapy in PBC and NASH","alternate_titles":[],"publication_year":2020,"publication_date":"2020-03-01","ids":{"openalex":"https://openalex.org/W3015589350","doi":"https://doi.org/10.1093/bmb/ldaa006","mag":"3015589350","pmid":"https://pubmed.ncbi.nlm.nih.gov/32282030"},"language":"en","primary_location":{"id":"doi:10.1093/bmb/ldaa006","doi":"https://doi.org/10.1093/bmb/ldaa006","is_oa":false,"landing_page_url":"https://doi.org/10.1093/bmb/ldaa006","pdf_url":null,"source":{"id":"https://openalex.org/S163102221","display_name":"British Medical Bulletin","issn_l":"0007-1420","issn":["0007-1420","1471-8391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Medical Bulletin","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3015589350"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035673731","display_name":"Roger William Chapman","orcid":"https://orcid.org/0000-0001-9147-2852","observed_orcids":["https://orcid.org/0000-0001-9147-2852"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210147381","display_name":"Oxford University Hospitals NHS Trust","ror":"https://ror.org/03h2bh287","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210147381"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Roger W Chapman","raw_affiliation_strings":["Nuffield Department of Medicine, University of Oxford, University Offices, Wellington Square, Oxford OX1 2JD, UK","Translational Gastroenterology Unit, Oxford University Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuffield Department of Medicine, University of Oxford, University Offices, Wellington Square, Oxford OX1 2JD, UK","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"Translational Gastroenterology Unit, Oxford University Hospital, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210147381"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020065368","display_name":"Kate Diana Lynch","orcid":"https://orcid.org/0000-0001-7748-2165","observed_orcids":["https://orcid.org/0000-0001-7748-2165"]},"institutions":[{"id":"https://openalex.org/I1320133117","display_name":"Royal Adelaide Hospital","ror":"https://ror.org/00carf720","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1320133117","https://openalex.org/I4392738059"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210147381","display_name":"Oxford University Hospitals NHS Trust","ror":"https://ror.org/03h2bh287","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU","GB"],"is_corresponding":false,"raw_author_name":"Kate D Lynch","raw_affiliation_strings":["Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Port Rd, Adelaide SA 5000, Australia","Faculty of Health and Medical Sciences, University of Adelaide, Port Road, Adelaide SA 5005, Australia","Nuffield Department of Medicine, University of Oxford, University Offices, Wellington Square, Oxford OX1 2JD, UK","Translational Gastroenterology Unit, Oxford University Hospital, Oxford, UK"],"raw_orcid":"https://orcid.org/0000-0001-7748-2165","affiliations":[{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Port Rd, Adelaide SA 5000, Australia","institution_ids":["https://openalex.org/I1320133117"]},{"raw_affiliation_string":"Faculty of Health and Medical Sciences, University of Adelaide, Port Road, Adelaide SA 5005, Australia","institution_ids":["https://openalex.org/I5681781"]},{"raw_affiliation_string":"Nuffield Department of Medicine, University of Oxford, University Offices, Wellington Square, Oxford OX1 2JD, UK","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"Translational Gastroenterology Unit, Oxford University Hospital, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210147381"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5035673731"],"corresponding_institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210147381"],"apc_list":{"value":3308,"currency":"GBP","value_usd":4362},"apc_paid":null,"fwci":6.0,"has_fulltext":true,"cited_by_count":125,"citation_normalized_percentile":{"value":0.97940295,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"133","issue":"1","first_page":"95","last_page":"104"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11834","display_name":"Liver Diseases and Immunity","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11834","display_name":"Liver Diseases and Immunity","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.007300000172108412,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.007000000216066837,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obeticholic-acid","display_name":"obeticholic acid","score":1.0},{"id":"https://openalex.org/keywords/farnesoid-x-receptor-agonist","display_name":"farnesoid X receptor agonist","score":0.8899999856948853},{"id":"https://openalex.org/keywords/primary-biliary-cholangitis","display_name":"primary biliary cirrhosis","score":0.9649999737739563},{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":1.0},{"id":"https://openalex.org/keywords/bile-acid-analogues","display_name":"bile acid analogues","score":0.7900000214576721},{"id":"https://openalex.org/keywords/ursodeoxycholic-acid","display_name":"ursodeoxycholic acid","score":0.8830000162124634},{"id":"https://openalex.org/keywords/fgf19","display_name":"FGF19","score":0.8949999809265137},{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.8709999918937683},{"id":"https://openalex.org/keywords/serum-alkaline-phosphatase","display_name":"serum alkaline phosphatase","score":0.6930000185966492},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.9589999914169312},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.5830000042915344},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.7059999704360962},{"id":"https://openalex.org/keywords/drug-costs","display_name":"drug costs","score":0.5220000147819519},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C2777067796","wikidata":"https://www.wikidata.org/wiki/Q15708271","display_name":"Obeticholic acid","level":4,"score":0.9765796065330505},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6569435000419617},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31418246030807495},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000099150","descriptor_name":"Receptor, Farnesoid X-Activated","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002635","descriptor_name":"Chenodeoxycholic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002635","descriptor_name":"Chenodeoxycholic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005765","descriptor_name":"Gastrointestinal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008105","descriptor_name":"Liver Cirrhosis, Biliary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008105","descriptor_name":"Liver Cirrhosis, Biliary","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018160","descriptor_name":"Receptors, Cytoplasmic and Nuclear","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D065626","descriptor_name":"Non-alcoholic Fatty Liver Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D065626","descriptor_name":"Non-alcoholic Fatty Liver Disease","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1093/bmb/ldaa006","doi":"https://doi.org/10.1093/bmb/ldaa006","is_oa":false,"landing_page_url":"https://doi.org/10.1093/bmb/ldaa006","pdf_url":null,"source":{"id":"https://openalex.org/S163102221","display_name":"British Medical Bulletin","issn_l":"0007-1420","issn":["0007-1420","1471-8391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Medical Bulletin","raw_type":"journal-article"},{"id":"pmid:32282030","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32282030","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British medical bulletin","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1726014254","https://openalex.org/W1940482586","https://openalex.org/W2059613020","https://openalex.org/W2062812115","https://openalex.org/W2089526803","https://openalex.org/W2095160124","https://openalex.org/W2106768039","https://openalex.org/W2119287426","https://openalex.org/W2122860085","https://openalex.org/W2148535164","https://openalex.org/W2152758419","https://openalex.org/W2518389324","https://openalex.org/W2522393659","https://openalex.org/W2565693018","https://openalex.org/W2605729742","https://openalex.org/W2735553444","https://openalex.org/W2761773602","https://openalex.org/W2794998501","https://openalex.org/W2807617765","https://openalex.org/W2886216103","https://openalex.org/W2922727372","https://openalex.org/W2937900320","https://openalex.org/W2939211606","https://openalex.org/W2941151920","https://openalex.org/W2948017058"],"related_works":["https://openalex.org/W2953057777","https://openalex.org/W4322741348","https://openalex.org/W3138091611","https://openalex.org/W3000690474","https://openalex.org/W4319656375","https://openalex.org/W2582629868","https://openalex.org/W2148535164","https://openalex.org/W2921843901","https://openalex.org/W1920851409","https://openalex.org/W2527742702"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Obeticholic":[1],"acid":[2,9],"(OCA)":[3],"is":[4,13,107,167,201,240],"a":[5,22,56,62,231,248,299],"semi-synthetic":[6],"hydrophobic":[7],"bile":[8],"(BA)":[10],"analogue":[11],"that":[12,202],"highly":[14],"selective":[15],"agonist":[16],"of":[17,30,43,61,64,138,161,193,203,214,259,282,302],"farnesoid":[18],"X":[19],"receptor":[20],"(FXR),":[21],"key":[23],"nuclear":[24],"BA":[25],"receptor,":[26],"which":[27,206],"induces":[28],"expression":[29],"gut-derived":[31],"hormones,":[32],"in":[33,93,130,175,196,212,225,234,252,265,275,286],"particular":[34],"fibroblast":[35],"growth":[36],"factor":[37],"19.":[38],"The":[39,189],"resulting":[40],"beneficial":[41],"effects":[42,192,281,304],"OCA":[44,89,106,143,166,194,260,283],"on":[45,284],"glucose":[46],"and":[47,50,71,116,154,199,288,308],"lipid":[48,227],"metabolism":[49],"particularly":[51],"hepatic":[52],"inflammation":[53],"make":[54],"it":[55],"candidate":[57],"for":[58,124,135,173],"the":[59,108,113,133,136,168,255,279],"treatment":[60,137,195,210],"variety":[63],"conditions":[65],"including":[66],"primary":[67],"biliary":[68],"cholangitis":[69],"(PBC)":[70],"nonalcoholic":[72],"steatohepatitis":[73],"(NASH).":[74],"SOURCES":[75],"OF":[76,164,187],"DATA:":[77],"In":[78,216],"PBC":[79,174,198,287],"patients":[80,177,219],"who":[81,178],"have":[82],"not":[83,241],"initially":[84],"responded":[85],"to":[86,98,180,183,209,277],"ursodeoxycholic":[87,184],"acid,":[88],"has":[90,144],"been":[91,145],"shown":[92,146],"double-blind":[94],"controlled":[95],"clinical":[96,141,272],"trials":[97,273],"significantly":[99],"reduce":[100],"serum":[101,226],"alkaline":[102],"phosphatase.":[103],"To":[104],"date,":[105],"only":[109],"therapy":[110,123,172,311],"licensed":[111],"by":[112,118,149],"FDA,":[114],"EMA":[115],"endorsed":[117],"NICE":[119],"as":[120],"second":[121,170],"line":[122,171],"PBC.No":[125],"medications":[126],"are":[127,274,305],"currently":[128],"approved":[129],"Europe":[131],"or":[132],"USA":[134],"NASH.In":[139,253],"recent":[140],"trials,":[142],"encouraging":[147],"results":[148],"improving":[150],"liver":[151,156],"blood":[152],"tests":[153],"reducing":[155],"fibrosis":[157],"with":[158,298,312],"no":[159],"worsening":[160],"NASH.":[162,289],"AREAS":[163,186,290],"AGREEMENT:":[165],"established":[169],"those":[176],"fail":[179],"adequately":[181],"respond":[182],"acid.":[185],"CONTROVERSY:":[188],"main":[190],"side":[191,303],"both":[197],"NASH":[200],"dose-dependent":[204],"pruritis":[205],"can":[207],"lead":[208],"discontinuation":[211],"~1-10%":[213],"patients.":[215],"addition,":[217,254],"OCA-treated":[218],"may":[220,261,315],"also":[221],"exhibit":[222],"(reversible)":[223],"alterations":[224],"levels;":[228],"most":[229],"notably":[230],"small":[232],"decrease":[233],"high":[235,257],"density":[236],"lipoprotein":[237],"cholesterol.":[238],"It":[239],"yet":[242],"known":[243],"whether":[244],"these":[245],"changes":[246],"carry":[247],"long-term":[249,280],"cardiovascular":[250],"risk":[251],"relatively":[256],"cost":[258],"limit":[262],"its":[263],"use":[264],"cash-limited":[266],"health":[267],"systems.":[268],"GROWING":[269],"POINTS:":[270],"Additional":[271],"progress":[276],"ascertain":[278],"survival":[285],"TIMELY":[291],"FOR":[292],"DEVELOPING":[293],"RESEARCH:":[294],"New":[295],"FXR":[296],"agonists":[297],"lower":[300],"rate":[301],"being":[306],"developed":[307],"trialed.":[309],"Combination":[310],"other":[313],"agents":[314],"offer":[316],"increased":[317],"efficacy.":[318]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3015589350","counts_by_year":[{"year":2026,"cited_by_count":16},{"year":2025,"cited_by_count":21},{"year":2024,"cited_by_count":37},{"year":2023,"cited_by_count":19},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2020-04-17T00:00:00"}
